SAN ANTONIO – StemBioSys Inc. has announced that they are working on two projects that are being funded from separate successful Small Business Innovative Research (SBIR) grant applications.

Gemini Bio-Products adds StemBioSys products to its portfolio

WEST SACRAMENTO, CA and SAN ANTONIO, TX, February 11, 2019 – Gemini Bio-Products (“Gemini”) and StemBioSys are pleased to announce a strategic partnership that will bring StemBioSys’ entire selection of matrices and cells into the Gemini portfolio. Launching this week, customers will now have the ability to purchase StemBioSys’ proprietary and innovative CELLvo™ products directly from Gemini.

SAN ANTONIO – StemBioSys Inc. announced today that they have co-authored a paper which has been published in the peer reviewed journal Acta Biomaterialia on an innovative use of its technology. The company also announced expansion of their product offerings and outlined its product development plans for 2019.

StemBioSys Inc. announced today a new branding identity for its cell research products and two new products that are the first to be marketed under the new brand
name.

StemBioSys Inc. announced today that it has entered into an agreement with Caltag Medsystems Ltd. to distribute and market StemBioSys products. Caltag will distribute StemBioSys products in the European Union.